Literature DB >> 32720414

Drug use associated tricuspid valve infective endocarditis in pregnancy.

Dishen Lin1, Clancy W Mullan1, Uma Deshmukh2, Mert Ozan Bahtiyar2, Hillary Hosier2, Heather Lipkind2, Sonya Abdel-Razeq2, Saurabh Ranjan3, Gilead Lancaster3, Colleen Pietras1.   

Abstract

BACKGROUND AND AIM: We report a case of intravenous drug use associated tricuspid valve endocarditis in a 28-year-old pregnant female at 26-week gestation.
METHODS: Patient management required a multidisciplinary collaboration between cardiac surgery, obstetrics and gynecology, and neonatal critical care.
RESULTS: Despite appropriate intravenous antibiotics, the patient developed life-threatening complications and underwent planned cesarean delivery at 28 weeks 6 days gestation followed by interval tricuspid valve replacement 1 week later.
CONCLUSIONS: Both the patient and her infant were successfully managed through the perioperative period.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  valve repair/replacement

Mesh:

Substances:

Year:  2020        PMID: 32720414     DOI: 10.1111/jocs.14888

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  1 in total

1.  Tricuspid valve endocarditis in pregnancy: a case report and review of the literature.

Authors:  Robert Libera; Kyle Macaulay; Anthony A Donato; Jared Green; Christine McCarty
Journal:  J Community Hosp Intern Med Perspect       Date:  2021-01-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.